RESMED INC — Director's Dealing 2019

Jul 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-07-03

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-03	ResMed Common Stock	M	4367	$52.02	Acquired	122250	Direct
2019-07-03	ResMed Common Stock	S	4131	$123.827	Disposed	118119	Direct
2019-07-03	ResMed Common Stock	S	236	$124.398	Disposed	117883	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-03	ResMed Common Stock Options	$52.02	M	4367	Disposed	2021-11-19	ResMed Commmon Stock (4367)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from $123.22 to $124.16. The price reported above reflects the weighted average sale price.

F3: This transaction was executed in multiple trades at prices ranging from $124.22 to 124.58. The price reported above reflects the weighted average sale price.